General Medicine

Path Healthcare Systems Corp dba General Medicine, based in the US, provides a wide array of healthcare services to improve patient care through innovative medical consultations, prescription services, and laboratory testing, both in-person and virtually. Founded in Salt Lake City, US, Path Healthcare Systems Corp dba General Medicine specializes in healthcare delivery, focusing on patient access to medical professionals for various conditions. In May 2025, General Medicine raised USD 21. 25 million in series A funding led by investor Matrix Partners, with participation from other investors BoxGroup, Founder Collective, VXI Capital, and JSL Health Capital.

Ashwin Muralidharan (CEO) and Elliot Cohen co-founded the firm. Their core product offerings include general and specialty medical consultations, prescription services, and laboratory testing, which are accessible through both in-person and virtual visits. The company addresses various health concerns, facilitating immediate access to medical professionals for conditions such as urinary tract infections, cardiology, dermatology, and more. General Medicine operates primarily in the United States, targeting a diverse clientele that encompasses individuals seeking urgent care, specialty consultations, and routine medical services.

The service framework is designed to connect users with healthcare providers efficiently, ensuring patients receive timely medical attention and personalized treatment plans. General Medicine's revenue model is structured around direct-to-consumer transactions, where patients pay for services rendered. Patients can engage with a range of specialty care options across several disciplines, and the pricing reflects the nature of the services provided. Customers can expect to pay varying amounts based on their insurance status and the complexity of services accessed, ensuring a transparent fee structure that supports both accessibility and quality care.

Through this model, General Medicine builds a revenue stream primarily from individual patient interactions rather than partnerships or subscriptions. In May 2025, General Medicine raised USD 21. 25 million in series A led by Matrix Partners to enhance their clinical capacity and broaden the range of accessible healthcare services. The company plans to introduce new healthcare services soon and is actively targeting expansion into additional markets within the US to increase its reach by the end of 2026.